NCT00243633

Brief Summary

The conventional sonography is frequently used to detect incidental focal liver lesions because of its availability, innocuity and low cost. Nevertheless, sensibility and specificity of conventional sonography does not exceed 70% for tumoral affections. Consequently the interest of this practice must be reconsidered by studying its ratio cost/diagnosis contribution. These limitations of conventional sonography have led to the use of other imaging modalities and invasive or costly procedures such as computed tomography (CT), magnetic resonance imaging (MRI) or biopsy. The availability of real-time contrast-enhanced ultrasound imaging (CEUS) has changed the strategy in the characterization of focal liver lesions, on healthy or cirrhotic liver in a neoplastic context or not, without inconvenience for the patient. The aim of the present study is to evaluate the place of CEUS in term of diagnostic relevance and catch of load cost, in the characterization of focal liver lesions detected but not characterized by CT or conventional sonography.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
878

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2005

Typical duration for not_applicable

Geographic Reach
1 country

15 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2005

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

October 21, 2005

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 24, 2005

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2006

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2007

Completed
Last Updated

December 23, 2025

Status Verified

December 1, 2025

Enrollment Period

1.7 years

First QC Date

October 21, 2005

Last Update Submit

December 16, 2025

Conditions

Keywords

focal liver lesionscontrast-enhanced ultrasound sonographycirrhosissuspected liver metastasessuspected liver cirrhosis

Outcome Measures

Primary Outcomes (1)

  • Medical and economic interest of CEUS

Secondary Outcomes (3)

  • Method acceptability

  • Contrast-enhanced ultrasound sonography tolerance

  • Harmony inter-readers

Interventions

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Target focal liver lesion of size lower than 10 cm and higher than 5 mm detected by conventional ultrasonography

You may not qualify if:

  • Patients with acute coronary syndrome or clinically unstable ischaemic cardiac disease, including: myocardial infarction, recent coronary artery intervention, acute cardiac failure (within last month), acute endocarditis and prosthetic valves.
  • Pregnant and lactating women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (15)

CHRU d'ANGERS

Angers, 49033, France

Location

Hôpital Saint-Jacques, CHRU Besancon

Besançon, 25000, France

Location

Hôpital Saint-André, CHRU Bordeaux

Bordeaux, 33075, France

Location

Hôpital Beaujon, Assistance Publique Hôpitaux de Paris

Clichy, 92118, France

Location

Hospices Civils de Lyon

Lyon, 69003, France

Location

Hôpital Saint-Eloi, CHRU Montpellier

Montpellier, 34295, France

Location

Hôpital Pitié Salpétrière, Assistance Publique Hôpitaux de Paris

Paris, 75651, France

Location

Hôpital Necker, Assistance Publique Hôpitaux de Paris

Paris, 75743, France

Location

Hôpital La Milétrie, CHRU Poitiers

Poitiers, 86000, France

Location

Hôpital Robert Debré, CHRU Reims

Reims, 51092, France

Location

Hôpital Nord, CHRU Saint-Etienne

Saint-Etienne, 42055, France

Location

Hôpital Bretonneau, CHRU Tours

Tours, 37044, France

Location

Service de Radiologie, Hôpital d'Enfants de Brabois

Vandœuvre-lès-Nancy, 54511, France

Location

Hôpital Paul Brousse, Assistance Publique Hôpitaux de Paris

Villejuif, 94804, France

Location

Institut Gustave Roussy

Villejuif, 94805, France

Location

Related Publications (8)

  • Kim TK, Choi BI, Hong HS, Choi BY, Han JK. Improved imaging of hepatic metastases with delayed pulse inversion harmonic imaging using a contrast agent SH U 508A: preliminary study. Ultrasound Med Biol. 2000 Nov;26(9):1439-44. doi: 10.1016/s0301-5629(00)00268-4.

    PMID: 11179618BACKGROUND
  • Albrecht T, Blomley MJ, Burns PN, Wilson S, Harvey CJ, Leen E, Claudon M, Calliada F, Correas JM, LaFortune M, Campani R, Hoffmann CW, Cosgrove DO, LeFevre F. Improved detection of hepatic metastases with pulse-inversion US during the liver-specific phase of SHU 508A: multicenter study. Radiology. 2003 May;227(2):361-70. doi: 10.1148/radiol.2272011833. Epub 2003 Mar 20.

    PMID: 12649417BACKGROUND
  • Quaia E, Bertolotto M, Forgacs B, Rimondini A, Locatelli M, Mucelli RP. Detection of liver metastases by pulse inversion harmonic imaging during Levovist late phase: comparison with conventional ultrasound and helical CT in 160 patients. Eur Radiol. 2003 Mar;13(3):475-83. doi: 10.1007/s00330-002-1670-1. Epub 2002 Sep 26.

    PMID: 12594549BACKGROUND
  • Bernatik T, Becker D, Neureiter D, Hansler J, Frieser M, Schaber S, Hahn EG, Strobel D. [Detection of liver metastases--comparison of contrast--enhanced ultrasound using first versus second generation contrast agents]. Ultraschall Med. 2003 Jun;24(3):175-9. doi: 10.1055/s-2003-40060. German.

    PMID: 12817311BACKGROUND
  • Basilico R, Blomley MJ, Harvey CJ, Filippone A, Heckemann RA, Eckersley RJ, Cosgrove DO. Which continuous US scanning mode is optimal for the detection of vascularity in liver lesions when enhanced with a second generation contrast agent? Eur J Radiol. 2002 Mar;41(3):184-91. doi: 10.1016/s0720-048x(01)00459-4.

    PMID: 11861092BACKGROUND
  • Leen E, Angerson WJ, Yarmenitis S, Bongartz G, Blomley M, Del Maschio A, Summaria V, Maresca G, Pezzoli C, Llull JB. Multi-centre clinical study evaluating the efficacy of SonoVue (BR1), a new ultrasound contrast agent in Doppler investigation of focal hepatic lesions. Eur J Radiol. 2002 Mar;41(3):200-6. doi: 10.1016/s0720-048x(01)00457-0.

    PMID: 11861094BACKGROUND
  • Tranquart F, Bleuzen A, Tchuenbou J. [Contrast ultrasound imaging in focal liver lesions: diagnostic value and guidelines]. J Radiol. 2004 May;85(5 Pt 2):680-9. doi: 10.1016/s0221-0363(04)97649-4. French.

    PMID: 15238869BACKGROUND
  • Tranquart F, Correas JM, Ladam Marcus V, Manzoni P, Vilgrain V, Aube C, Elmaleh A, Chami L, Claudon M, Cuilleron M, Diris B, Garibaldi F, Lucidarme O, Marion D, Beziat C, Rode A, Tasu JP, Trillaud H, Bleuzen A, Le Gouge A, Giraudeau B, Rusch E. [Real-time contrast-enhanced ultrasound in the evaluation of focal liver lesions: diagnostic efficacy and economical issues from a French multicentric study]. J Radiol. 2009 Jan;90(1 Pt 2):109-22. doi: 10.1016/s0221-0363(09)70089-7. French.

MeSH Terms

Conditions

Liver NeoplasmsLiver CirrhosisFibrosis

Condition Hierarchy (Ancestors)

Digestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesLiver DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Jean Michel CORREAS, Dr

    Necker Hospital

    PRINCIPAL INVESTIGATOR
  • François TRANQUART, Pr

    University Hospital, Tours

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 21, 2005

First Posted

October 24, 2005

Study Start

April 1, 2005

Primary Completion

December 1, 2006

Study Completion

August 1, 2007

Last Updated

December 23, 2025

Record last verified: 2025-12

Locations